In animal experiment, the platelet inhibitor aspirin can reduce inflammation and atherosclerosis in both apolipoprotein E deficient (apoE−/–) mice and low-density lipoprotein receptor deficient (Ldlr−/–) mice (45). Here, APOE is linked to atherosclerosis.